| Serial Number | 88655362 |
| Word Mark | R2 REVLIMID/RITUXIMAB |
| Filing Date | Tuesday, October 15, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 9, 2020 |
| Registration Number | 6073615 |
| Registration Date | Tuesday, June 9, 2020 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 24, 2020 |
| Description of Mark | The mark consists of the letter "R" appearing with the exponent "2" in blue next to the wording "REVLIMID/" with the letters appearing in black and the forward slash appearing in yellow, above the wording "RITUXIMAB" appearing in black. |
| Goods and Services | Pharmaceutical preparations for the treatment of certain cancers; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; all the aforementioned goods being comprised in part of rituximab |
| Indication of Colors claimed | The color(s) blue, black and yellow is/are claimed as a feature of the mark. |
| Goods and Services | Medical information and counseling in the field of pharmaceuticals and safety issues pertaining to pharmaceuticals, and providing medical information in the aforementioned fields by distributing written materials in connection therewith; programs in the nature of providing medical information and counseling in the field of lenalidomide and rituximab and safety issues pertaining to lenalidomide and rituximab, and providing medical information in the aforementioned fields by distributing written materials in connection therewith; providing a web site featuring medical information; providing an internet website for medical professionals and medical patients featuring medical information; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing pharmaceutical advice; providing medical information, consultancy and advisory services; all the aforementioned services relating to rituximab |
| NOT AVAILABLE | "RITUXIMAB" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, October 19, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, May 28, 2019 |
| First Use In Commerce Date | Tuesday, May 28, 2019 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, October 19, 2019 |
| Primary Code | 044 |
| First Use Anywhere Date | Tuesday, May 28, 2019 |
| First Use In Commerce Date | Tuesday, May 28, 2019 |
| Party Name | Celgene Corporation |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Summit, NJ 07901 |
| Party Name | Celgene Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Summit, NJ 07901 |
| Party Name | Celgene Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Summit, NJ 07901 |
| Event Date | Event Description |
| Friday, October 18, 2019 | NEW APPLICATION ENTERED |
| Saturday, October 19, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 22, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, January 7, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 30, 2019 | ASSIGNED TO EXAMINER |
| Monday, January 6, 2020 | NON-FINAL ACTION WRITTEN |
| Monday, January 6, 2020 | NON-FINAL ACTION E-MAILED |
| Monday, January 6, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 8, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, January 7, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 7, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, January 13, 2020 | ASSIGNED TO LIE |
| Thursday, February 13, 2020 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Monday, February 17, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, February 17, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Monday, February 17, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, February 17, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Monday, February 17, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 4, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 24, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 24, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 9, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Friday, December 9, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, December 9, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, January 28, 2020 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Friday, December 9, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, December 9, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, December 9, 2022 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Monday, June 9, 2025 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Friday, December 9, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |